Back to the full story9 sources · Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer◆ Timeline
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
10 reports in the order each was filed. Tap any entry to open that report at its source.
- 01Ars TechnicaAug 19, 4:53 PMMRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
- 02AxiosAug 19, 8:04 PMModerna and Merck shares soar on mRNA cancer vaccine
- 03CNBCAug 19, 8:34 PMCancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
- 04Scientific AmericanAug 19, 8:45 PMModerna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
- 05CBS News — TopAug 19, 11:33 PMModerna stock surges as melanoma vaccine trial shows "landmark moment
- 06NatureAug 20, 12:00 AMModerna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
- 07CBS NewsAug 20, 1:03 AMHow Moderna's melanoma mRNA vaccine could fight deadliest skin cancer
- 08AxiosAug 20, 1:31 PMModerna and Merck shares soar on mRNA cancer vaccine
- 09PBS NewsHourAug 20, 2:49 PMModerna shares surge after it says experimental mRNA cancer treatment passed key test
- 10GizmodoAug 20, 4:15 PMModerna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer